Pneumococcal Septic Arthritis among Adults, France, 2010-2018

Emerg Infect Dis. 2025 Jan;31(1). doi: 10.3201/eid3101.240321.

Abstract

Streptococcus pneumoniae infection is considered an uncommon cause of arthritis in adults. To determine the clinical and microbiological characteristics of pneumococcal septic arthritis, we retrospectively studied a large series of cases among adult patients during the 2010-2018 conjugate vaccine era in France. We identified 110 patients (56 women, 54 men; mean age 65 years), and cases included 82 native joint infections and 28 prosthetic joint infections. Most commonly affected were the knee (50/110) and hip (25/110). Concomitant pneumococcal infections were found in 37.2% (38/102) and bacteremia in 57.3% (55/96) of patients, and underlying conditions were noted for 81.4% (83/102). Mortality rate was 9.4% (8/85). The proportion of strains not susceptible to penicillin was 29.1% (32/110). Of the 55 serotyped strains, 31 (56.4%) were covered by standard pneumococcal vaccines; however, several nonvaccine serotypes (mainly 23B, 24F, and 15A) had emerged, for which susceptibility to β-lactams was low.

Keywords: France; Streptococcus pneumoniae; adult; antimicrobial resistance; bacteria; joint infection; septic arthritis; vaccines.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents* / pharmacology
  • Anti-Bacterial Agents* / therapeutic use
  • Arthritis, Infectious* / drug therapy
  • Arthritis, Infectious* / epidemiology
  • Arthritis, Infectious* / microbiology
  • Female
  • France / epidemiology
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Pneumococcal Infections* / drug therapy
  • Pneumococcal Infections* / epidemiology
  • Pneumococcal Infections* / microbiology
  • Pneumococcal Vaccines / immunology
  • Retrospective Studies
  • Serogroup
  • Streptococcus pneumoniae* / classification
  • Streptococcus pneumoniae* / drug effects
  • Streptococcus pneumoniae* / immunology
  • Streptococcus pneumoniae* / isolation & purification

Substances

  • Anti-Bacterial Agents
  • Pneumococcal Vaccines